The Global Generic Drugs Market, valued at USD 487.21 Billion in 2024, is poised to reach USD 898 Billion by 2035, advancing ...
Fitch Ratings downgraded from 'B+' to 'B' the LT Int. Scale (foreign curr.) credit rating of Bellis Finco on November 24, 2025. The outlook is negative.
This website uses cookies for convenience and personalization. Cookies store useful information on your computer so that we can improve the operational efficiency and accuracy of our website for you.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback